Your browser doesn't support javascript.
loading
Class-specific relative genetic contribution for key antiretroviral drugs.
Siccardi, Marco; Olagunju, Adeniyi; Simiele, Marco; D'Avolio, Antonio; Calcagno, Andrea; Di Perri, Giovanni; Bonora, Stefano; Owen, Andrew.
Afiliação
  • Siccardi M; Molecular and Clinical Pharmacology, Institute of Translational Medicine, University of Liverpool, Liverpool, UK siccardi@liverpool.ac.uk.
  • Olagunju A; Molecular and Clinical Pharmacology, Institute of Translational Medicine, University of Liverpool, Liverpool, UK Faculty of Pharmacy, Obafemi Awolowo University, Ile-Ife, Nigeria.
  • Simiele M; Department of Infectious Diseases, University of Torino, Amedeo di Savoia Hospital, Torino, Italy.
  • D'Avolio A; Department of Infectious Diseases, University of Torino, Amedeo di Savoia Hospital, Torino, Italy.
  • Calcagno A; Department of Infectious Diseases, University of Torino, Amedeo di Savoia Hospital, Torino, Italy.
  • Di Perri G; Department of Infectious Diseases, University of Torino, Amedeo di Savoia Hospital, Torino, Italy.
  • Bonora S; Department of Infectious Diseases, University of Torino, Amedeo di Savoia Hospital, Torino, Italy.
  • Owen A; Molecular and Clinical Pharmacology, Institute of Translational Medicine, University of Liverpool, Liverpool, UK.
J Antimicrob Chemother ; 70(11): 3074-9, 2015 Nov.
Article em En | MEDLINE | ID: mdl-26221018
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Farmacogenética / Plasma / Antirretrovirais Idioma: En Ano de publicação: 2015 Tipo de documento: Article País de afiliação: Reino Unido
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Farmacogenética / Plasma / Antirretrovirais Idioma: En Ano de publicação: 2015 Tipo de documento: Article País de afiliação: Reino Unido